✦ LIBER ✦

Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: Prospective data from phase 1

✍ Scribed by Jonathan M. Meyer; Vicki G. Davis; Donald C. Goff; Joseph P. McEvoy; Henry A. Nasrallah; Sonia M. Davis; Robert A. Rosenheck; Gail L. Daumit; John Hsiao; Marvin S. Swartz; T. Scott Stroup; Jeffrey A. Lieberman

Book ID: 119363839
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 491 KB
Volume: 101
Category: Article
ISSN: 0920-9964
DOI: 10.1016/j.schres.2007.12.487

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of antipsychotic treatment on non

Impact of antipsychotic treatment on nonfasting triglycerides in the CATIE Schizophrenia Trial phase 1

✍ Jonathan M. Meyer; Vicki G. Davis; Joseph P. McEvoy; Donald C. Goff; Henry A. Na 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 204 KB

Prevalence of the metabolic syndrome in

Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III

✍ Joseph P. McEvoy; Jonathan M. Meyer; Donald C. Goff; Henry A. Nasrallah; Sonia M 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 157 KB

Changes in weight and metabolic paramete

Changes in weight and metabolic parameters during treatment with antipsychotics and metformin: do the data inform as to potential guideline development? A systematic review of clinical studies

✍ C. J. Bushe; A. J. Bradley; S. Doshi; J. Karagianis 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB